PRKAA2 and cancer: Other studies have shown that AMPK negatively regulates CSCs in different cancer types through the inhibition of protein prenylation, reactive oxygen species-dependent autophagy and direct Nanog degradation (Seo et al., 2020; Wu et al., 2019; Zhao et al., 2019).